Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Strengths and limitations of laboratory procedures for microRNA detection.

Koshiol J, Wang E, Zhao Y, Marincola F, Landi MT.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):907-11. doi: 10.1158/1055-9965.EPI-10-0071. Epub 2010 Mar 23.

2.

MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer.

Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N.

BMC Cancer. 2010 Apr 29;10:173. doi: 10.1186/1471-2407-10-173.

3.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.

PMID:
20363096
4.

Development and application of a novel reverse transcription real-time PCR method for miR-499 quantification.

Zheng W, Di Y, Liu Y, Huang G, Zheng Y, Zhang Y, Fang W.

Clin Biochem. 2013 Oct;46(15):1566-71. doi: 10.1016/j.clinbiochem.2013.06.024. Epub 2013 Jul 18.

PMID:
23872321
5.

Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues.

Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, Jurisica I, Penn LZ, Liu FF.

Lab Invest. 2009 May;89(5):597-606. doi: 10.1038/labinvest.2009.12. Epub 2009 Mar 16. Erratum in: Lab Invest. 2009 Jun;89(6):726. Waldron, Levi [added].

6.

MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.

Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E.

Cancer. 2011 Apr 15;117(8):1630-9. doi: 10.1002/cncr.25724. Epub 2010 Nov 8.

7.

MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.

Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Michael MZ; South Australian Oesophageal Research Group.

Br J Surg. 2010 Jun;97(6):853-61. doi: 10.1002/bjs.7000.

PMID:
20301167
8.

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS.

Clin Chem. 2011 Jan;57(1):84-91. doi: 10.1373/clinchem.2010.151845. Epub 2010 Oct 29. Erratum in: Clin Chem. 2012 May;58(5):e1-6.

9.

A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Della Vittoria Scarpati G, Falcetta F, Carlomagno C, Ubezio P, Marchini S, De Stefano A, Singh VK, D'Incalci M, De Placido S, Pepe S.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1113-9. doi: 10.1016/j.ijrobp.2011.09.030. Epub 2011 Dec 13.

PMID:
22172905
10.

Microarray analysis of differentially expressed microRNAs in allergic rhinitis.

Shaoqing Y, Ruxin Z, Guojun L, Zhiqiang Y, Hua H, Shudong Y, Jie Z.

Am J Rhinol Allergy. 2011 Nov-Dec;25(6):e242-6. doi: 10.2500/ajra.2011.25.3682.

PMID:
22185732
11.

Identification and characterization of microRNAs in vascular smooth muscle cells from patients with abdominal aortic aneurysms.

Cheuk BL, Cheng SW.

J Vasc Surg. 2014 Jan;59(1):202-9. doi: 10.1016/j.jvs.2013.02.244. Epub 2013 Jun 5.

12.

Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.

Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C.

World J Surg. 2009 Apr;33(4):698-709. doi: 10.1007/s00268-008-9833-0. Review.

13.
14.

MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease.

Olaru AV, Yamanaka S, Vazquez C, Mori Y, Cheng Y, Abraham JM, Bayless TM, Harpaz N, Selaru FM, Meltzer SJ.

Inflamm Bowel Dis. 2013 Mar;19(3):471-80. doi: 10.1097/MIB.0b013e31827e78eb.

15.

Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available.

Benes V, Castoldi M.

Methods. 2010 Apr;50(4):244-9. doi: 10.1016/j.ymeth.2010.01.026. Epub 2010 Jan 28. Review.

PMID:
20109550
16.

Identification of suitable reference genes for hepatic microRNA quantitation.

Lamba V, Ghodke-Puranik Y, Guan W, Lamba JK.

BMC Res Notes. 2014 Mar 7;7:129. doi: 10.1186/1756-0500-7-129.

17.

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

Fritz HK, Lindgren D, Ljungberg B, Axelson H, Dahlb├Ąck B.

Eur J Cancer. 2014 Jul;50(10):1758-65. doi: 10.1016/j.ejca.2014.03.281. Epub 2014 Apr 30.

PMID:
24793999
18.

Normalization strategies for microRNA profiling experiments: a 'normal' way to a hidden layer of complexity?

Meyer SU, Pfaffl MW, Ulbrich SE.

Biotechnol Lett. 2010 Dec;32(12):1777-88. doi: 10.1007/s10529-010-0380-z. Epub 2010 Aug 12.

PMID:
20703800
19.

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.

White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM.

Br J Cancer. 2011 Nov 22;105(11):1741-9. doi: 10.1038/bjc.2011.401. Epub 2011 Oct 27.

20.

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC.

JAMA. 2008 Jan 30;299(4):425-36. doi: 10.1001/jama.299.4.425.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk